Front Row Advisors’s Veradigm MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-220
Closed -$2.09K – 866
2024
Q2
$2.09K Hold
220
– – ﹤0.01% 849
2024
Q1
$1.69K Buy
+220
New +$2K ﹤0.01% 855
2023
Q4
– Sell
-220
Closed -$2.89K – 834
2023
Q3
$2.89K Hold
220
– – ﹤0.01% 774
2023
Q2
$3K Hold
220
– – ﹤0.01% 778
2023
Q1
$3K Hold
220
– – ﹤0.01% 793
2022
Q4
$4K Hold
220
– – ﹤0.01% 710
2022
Q3
$3K Hold
220
– – ﹤0.01% 777
2022
Q2
$3K Hold
220
– – ﹤0.01% 781
2022
Q1
$5K Hold
220
– – ﹤0.01% 740
2021
Q4
$4K Hold
220
– – ﹤0.01% 807
2021
Q3
$3K Hold
220
– – ﹤0.01% 836
2021
Q2
$3K Hold
220
– – ﹤0.01% 840
2021
Q1
$3K Hold
220
– – ﹤0.01% 836
2020
Q4
$3K Hold
220
– – ﹤0.01% 799
2020
Q3
$3K Hold
220
– – ﹤0.01% 796
2020
Q2
$1K Hold
220
– – ﹤0.01% 961
2020
Q1
$1K Hold
220
– – ﹤0.01% 942
2019
Q4
$2K Hold
220
– – ﹤0.01% 823
2019
Q3
$2K Hold
220
– – ﹤0.01% 829
2019
Q2
$3K Hold
220
– – ﹤0.01% 783
2019
Q1
$2K Hold
220
– – ﹤0.01% 886
2018
Q4
$2K Hold
220
– – ﹤0.01% 852
2018
Q3
$3K Hold
220
– – ﹤0.01% 743
2018
Q2
$3K Hold
220
– – ﹤0.01% 796
2018
Q1
$3K Hold
220
– – ﹤0.01% 741
2017
Q4
$3K Buy
+220
New +$3.06K ﹤0.01% 640

Other funds holding MDRX

Front Row Advisors's MDRX Position: Q3 2024 in Review

Front Row Advisors sold out of Veradigm (MDRX) in Q3 2024, closing a stake of 220 shares — an estimated $2.09K sold.

Front Row Advisors first reported a position in MDRX in Q4 2017 and held it in 26 quarters. The position peaked at $5K in Q1 2022. 8 funds tracked by Wall St. Rank hold MDRX as of Q3 2024.

  • Front Row Advisors reported no remaining Veradigm position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 220 Veradigm shares in Q3 2024, an estimated $2.09K.
  • Front Row Advisors first reported a position in Veradigm in Q4 2017 and held it in 26 quarters.
  • Front Row Advisors's Veradigm position peaked at $5K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Veradigm as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.